Is Haemato AG halal to invest in?

According to Musaffa's Shariah screening methodology, Haemato AG (HAEK.HM) is currently classified as NOT HALAL as of January 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Haemato AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Haemato AG using these criteria to determine its compliance status.

Can Muslims buy shares of Haemato AG?

Muslim investors may consider investing in Haemato AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Haemato AG classified as NOT HALAL?

Musaffa determines the Shariah status of Haemato AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Haemato AG updated?

The Shariah compliance status of Haemato AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Haemato AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Haemato AG?

You can check the latest Shariah compliance status of Haemato AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Haemato AG HAEK.HM

€12.20 €0.50 (4.27%) 1D

Last Updated: May 14, 12:00 AM·HAM

HAEK.HM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 30, 2024

Report Source: 2023 2nd Quarter Report

Analyst's Ratings for Haemato AG (HAEK.HM)

Based on 7 analysts giving stock ratings to Haemato AG in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Haemato AG. Stock Analysis HAEK.HM

Germany Health Care Micro Cap Report: Q2, 2023

Haemato AG engages in the pharmaceutical industry. The firm operates in two segments specialty pharma and lifestyle and aesthetics. Specialty pharma segment includes the trade and production of drugs and preparations in the field of human immunodeficiency virus (HIV), oncology, rheumatology, neurology as well as cardiovascular diseases and other chronic diseases. Its lifestyle and aesthetics segment is an outcome of new subsidiary M1 Aesthetics GmbH which is into marketing of pharmaceutical, medical and med tech products for aesthetic surgery and cosmetic dermatology. The firm acts as a wholesaler and parallel importer. Its business is carried out by there companies Haemato pharma AG, Haemato Med GmbH, M1 Aesthetics GmbH. The company offers related support services.

Key Statistics of Haemato AG (HAEK.HM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€11.70€12.20

Today's Open

€11.70

Volume

100.00

P/E Ratio (TTM)

7.66

52 Week Range

€8.20€13.50

Market Cap

63.27M

Avg. Volume

896.00

Dividend Yield

Financial Metrics & Statements of Haemato AG (HAEK.HM)

FAQ's for Haemato AG (HAEK.HM)

According to Musaffa’s Shariah screening methodology, Haemato AG (HAEK.HM) is currently classified as NOT HALAL as of January 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.